Pay in 4 interest-free payments of $7.48 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
BPC-157 was placed on the FDA's Category 2 bulk drug substance list, meaning it cannot be compounded by commercial pharmaceutical companies
Some patients experience mild injection site reactions (redness, slight swelling) which typically resolve quickly
The only pathway is compounding
(2024) 73:864-P
Both BPC-157 and TB-500 in this formulation are research peptides endotoxin tested to confirm compliance with strict laboratory quality requirements, supporting reproducibility and experimental reliability
US$ 26.71
US$ 28.30
US$ 23.04
:max_bytes(150000):strip_icc()/Health-GettyImages-PharmacistsGLP1s-091528aad5314e0f94e92880dee97289.jpg)
US$ 25.55
US$ 21.47
US$ 28.89
